24-h uric acid excretion and the risk of kidney stones

被引:194
作者
Curhan, G. C. [1 ,2 ,3 ]
Taylor, E. N. [1 ,2 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Renal Div, Boston, MA USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
kidney stone;
D O I
10.1038/sj.ki.5002708
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
There is uncertainty about the relation between 24-h urinary uric acid excretion and the risk of calcium oxalate nephrolithiasis. In addition, the risk associated with different levels of other urinary factors needs clarification. We performed a cross-sectional study of 24-h urine excretion and the risk of kidney stone formation in 3350 men and women, of whom 2237 had a history of nephrolithiasis. After adjusting for other urinary factors, urinary uric acid had a significant inverse association with stone formation in men, a marginal inverse association with risk in younger women, and no association in older women. The risk of stone formation in men and women significantly rose with increasing urine calcium and oxalate, and significantly decreased with increasing citrate and urine volume, with the change in risk beginning below the traditional normal thresholds. Other urinary factors were also associated with risk, but this varied by age and gender. Our study does not support the prevailing belief that higher urine uric acid excretion increases the risk for calcium oxalate stone formation. In addition, the current definitions of normal levels for urinary factors need to be re-evaluated.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 17 条
[1]   Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension [J].
Butler, R ;
Morris, AD ;
Belch, JJF ;
Hill, A ;
Struthers, AD .
HYPERTENSION, 2000, 35 (03) :746-751
[2]   Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients [J].
Cardillo, C ;
Kilcoyne, CM ;
Cannon, RO ;
Quyyumi, AA ;
Panza, JA .
HYPERTENSION, 1997, 30 (01) :57-63
[3]   Kidney stone disease [J].
Coe, FL ;
Evan, A ;
Worcester, E .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) :2598-2608
[4]   MEDICAL PROGRESS - THE PATHOGENESIS AND TREATMENT OF KIDNEY-STONES [J].
COE, FL ;
PARKS, JH ;
ASPLIN, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (16) :1141-1152
[5]   HYPER-URICOSURIC CALCIUM-OXALATE NEPHROLITHIASIS [J].
COE, FL .
KIDNEY INTERNATIONAL, 1978, 13 (05) :418-426
[6]  
COE FL, 1974, NEW ENGL J MED, V291, P1344
[7]   Twenty-four-hour urine chemistries and the risk of kidney stones among women and men [J].
Curhan, GC ;
Willett, WC ;
Speizer, FE ;
Stampfer, MJ .
KIDNEY INTERNATIONAL, 2001, 59 (06) :2290-2298
[8]   OXALATE ABSORPTION AND POSTPRANDIAL URINE SUPERSATURATION IN AN EXPERIMENTAL HUMAN-MODEL OF ABSORPTIVE HYPERCALCIURIA [J].
ERICKSON, SB ;
COOPER, K ;
BROADUS, AE ;
SMITH, LH ;
WERNESS, PG ;
BINDER, HJ ;
DOBBINS, JW .
CLINICAL SCIENCE, 1984, 67 (01) :131-138
[9]   DOES HYPERURICOSURIA PLAY A ROLE IN CALCIUM-OXALATE LITHIASIS [J].
ETTINGER, B .
JOURNAL OF UROLOGY, 1989, 141 (03) :738-741
[10]   RANDOMIZED TRIAL OF ALLOPURINOL IN THE PREVENTION OF CALCIUM-OXALATE CALCULI [J].
ETTINGER, B ;
TANG, A ;
CITRON, JT ;
LIVERMORE, B ;
WILLIAMS, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (22) :1386-1389